ABSTRACT
PURPOSE: To evaluate the microvessel density by comparing the performance of anti-factor VIII-related antigen, anti-CD31 and anti-CD34 monoclonal antibodies in breast cancer. METHODS: Twenty-three postmenopausal women diagnosed with Stage II breast cancer submitted to definitive surgical treatment were evaluated. The monoclonal antibodies used were anti-factor VIII, anti-CD31 and anti-CD34. Microvessels were counted in the areas of highest microvessel density in ten random fields (200 x). The data were analyzed using the Kruskal-Wallis nonparametric test (p < 0.05). RESULTS: Mean microvessel densities with anti-factor VIII, anti-CD31 and anti-CD34 were 4.16 +/- 0.38, 4.09 +/- 0.23 and 6.59 +/- 0.42, respectively. Microvessel density as assessed by anti-CD34 was significantly greater than that detected by anti-CD31 or anti-factor VIII (p < 0.0001). There was no statistically significant difference between anti-CD31 and anti-factor VIII (p = 0.4889). CONCLUSION: The density of stained microvessels was greater and staining was more intense with anti-CD34 compared to anti-CD31 and anti-factor VIII-related antigen.
Subject(s)
Antigens, CD34/analysis , Breast Neoplasms/blood supply , Carcinoma, Ductal, Breast/blood supply , Microvessels/pathology , Neovascularization, Pathologic/pathology , Platelet Endothelial Cell Adhesion Molecule-1/analysis , von Willebrand Factor/analysis , Aged , Aged, 80 and over , Breast Neoplasms/pathology , Carcinoma, Ductal, Breast/pathology , Endothelium, Vascular/immunology , Endothelium, Vascular/pathology , Female , Humans , Middle AgedABSTRACT
Ectopic breast cancer is rare and when situated in the chest wall, it is even rarer. This report describes the case of an 86-year old Brazilian woman with a palpable carcinoma, located in the right inframammary fold, and right axillary adenopathy. The patient was submitted to excision of the accessory breast and to right axillary lymphadenectomy. All 28 resected lymph nodes contained metastatic cells. Diagnosis and treatment of ectopic breast cancer should be carried out early in view of its aggressivity.